Literature DB >> 11523565

Genetic susceptibility to MS: a second stage analysis in Canadian MS families.

D A Dyment1, C J Willer, B Scott, H Armstrong, A Ligers, J Hillert, D W Paty, S Hashimoto, V Devonshire, J Hooge, L Kastrukoff, J Oger, L Metz, S Warren, W Hader, C Power, A Auty, A Nath, R Nelson, M Freedman, D Brunet, J E Paulseth, G Rice, P O'Connor, P Duquette, Y Lapierre, G Francis, J P Bouchard, T J Murray, V Bhan, C Maxner, W Pryse-Phillips, M Stefanelli, A D Sadovnick, N Risch, G C Ebers.   

Abstract

Four published genome screens have identified a number of markers with increased sharing in multiple sclerosis (MS) families, although none has reached statistical significance. One hundred and five markers previously identified as showing increased sharing in Canadian, British, Finnish, and American genome screens were genotyped in 219 sibling pairs ascertained from the database of the Canadian Collaborative Project on Genetic Susceptibility to MS (CCPGSMS). No markers examined met criteria for significant linkage. Markers located at 5p14 and 17q22 were analyzed in a total of 333 sibling pairs and attained mlod scores of 2.27 and 1.14, respectively. The known HLA Class II DRB1 association with MS was confirmed (P<0.0001). Significant transmission disequilibrium was also observed for D17S789 at 17q22 (P=0.0015). This study highlights the difficulty of searching for genes with only mild-to-moderate effects on susceptibility, although large effects of specific loci may still be present in individual families. Future progress in the genetics of this complex trait may be helped by (1) focussing on more ethnically homogeneous samples, (2) using an increased number of MS families, and (3) using transmission disequilibrium analysis in candidate regions rather than the affected relative pair linkage analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523565     DOI: 10.1007/s100480100113

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  5 in total

Review 1.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

2.  Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Authors:  Eveliina Jakkula; Virpi Leppä; Anna-Maija Sulonen; Teppo Varilo; Suvi Kallio; Anu Kemppinen; Shaun Purcell; Keijo Koivisto; Pentti Tienari; Marja-Liisa Sumelahti; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Arpo Aromaa; Annette Bang Oturai; Helle Bach Søndergaard; Hanne F Harbo; Inger-Lise Mero; Stacey B Gabriel; Daniel B Mirel; Stephen L Hauser; Ludwig Kappos; Chris Polman; Philip L De Jager; David A Hafler; Mark J Daly; Aarno Palotie; Janna Saarela; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

3.  Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.

Authors:  M G Marrosu; E Cocco; G Costa; M R Murru; C Mancosu; R Murru; M Lai; C Sardu; P Contu
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

4.  Association between the IL7R T244I polymorphism and multiple sclerosis: a meta-analysis.

Authors:  Ruijie Zhang; Lian Duan; Yongshuai Jiang; Xuehong Zhang; Peng Sun; Jin Li; Mingming Zhang; Guoping Tang; Xing Wang; Xia Li
Journal:  Mol Biol Rep       Date:  2010-12-16       Impact factor: 2.316

5.  Segmental duplications flank the multiple sclerosis locus on chromosome 17q.

Authors:  Daniel C Chen; Janna Saarela; Royden A Clark; Timo Miettinen; Anthony Chi; Evan E Eichler; Leena Peltonen; Aarno Palotie
Journal:  Genome Res       Date:  2004-07-15       Impact factor: 9.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.